MARKHAM, ONTARIO--(CCNMatthews - Nov. 16, 2006) - Vesicare (Solifenacin succinate) has been approved by Health Canada and is now available for the treatment of overactive bladder (OAB). Approximately 12 per cent of Canadians suffer from OAB(1) a chronic medical condition causing a person to feel the overwhelming urge to urinate even when their bladder is not full.
